600062.SSChina Resources Double-Crane Pharmaceutical Co.,Ltd.Health Care>PharmaceuticalsOct 23, 2026 — Q3 2026 Earnings ReleaseChart by TradingViewThe scheduleFri23OctQ3 2026 Earnings ReleaseOct 23, 2026→Nov 6, 2026Wed25NovNational Reimbursement Drug List (NRDL) UpdateNov 25, 2026→Dec 9, 2026Annual updates to the NRDL, detailing inclusion and price adjustments for CR Double-Crane's generic and specialized portfolio.Tue15DecLier Chemical Deal FinalizationDec 15, 2026→Dec 29, 2026Anticipated final shareholder and regulatory approvals for the 23.5% stake acquisition in Lier Chemical for CNY 5.66 billion.Thu25MarQ4 2026 Earnings ReleaseMar 25, 2027→Apr 8, 2027Annual FY 2026 financial results, dividend declaration, and management's initial 2027 outlook.Tue15JunSynthetic Biology Pipeline UpdateJun 15, 2027→Jun 29, 2027Strategic update on commercializing synthetic biology products leveraging the newly acquired Lier Chemical platform.
